Tułecki Łukasz, Czajkowski Marek, Targońska Sylwia, Tomków Konrad, Nowosielecka Dorota, Jacheć Wojciech, Polewczyk Anna, Kutarski Andrzej
Department of Cardiac Surgery, The Pope John Paul II Province Hospital, Zamosc, Poland.
Department of Cardiac Surgery, Medical University of Lublin, Lublin, Poland.
Kardiochir Torakochirurgia Pol. 2022 Sep;19(3):122-129. doi: 10.5114/kitp.2022.119759. Epub 2022 Oct 8.
The guidelines stress the importance of cardiac surgery in the management of life-threatening complications arising from lead removal.
To delineate the roles of the cardiac surgeon during transvenous lead extraction (TLE).
3207 patients (38.7% F), average age 65.7 years, underwent the extraction of PM/ICD leads using standard non-powered mechanical systems within the last 14 years.
Procedural success 96.1%, clinical success 97.8%, procedure-related death 0.18%, major complications 1.9% (cardiac tamponade 1.2%, hemothorax 0.2%, tricuspid valve damage 0.3%, stroke and pulmonary embolism < 1%). The roles for cardiac surgery in TLE have been categorized into five areas: 1. Emergency cardiac surgery (1.18% of all patients), 2. Late surgical intervention (TLE-related tricuspid valve dysfunction) (0.44%), 3. Cardiac surgery complementing partially successful TLE (0.68%: removal of lead fragments), 4. Epicardial pacemaker implantation through sternotomy for the above-mentioned reasons (0.65%), 5. Delayed surgical intervention after TLE to place epicardial LV leads (0.53%). Additionally, surgical experience can help in prevention and treatment of wound infection after TLE.
Emergency cardiac surgery (mainly due to severe bleeding) is still the most frequent reason for intervention (33.63% (38/113) of all surgical procedures). The other areas of surgical interventions in lead management are: cardiac surgery complementing partially successful TLE, repair or replacement of the malfunctioning tricuspid valve secondary to lead extraction and implantation of permanent epicardial pacing leads after sternotomy or epicardial left ventricle lead to optimize cardiac resynchronization. Experience of a single high-volume lead extraction center confirms the need for close collaboration between the cardiologist and the cardiac surgeon, whose role goes far beyond mere surgical standby.
指南强调心脏手术在处理因导线拔除引起的危及生命并发症方面的重要性。
明确心脏外科医生在经静脉导线拔除术(TLE)中的作用。
在过去14年中,3207例患者(女性占38.7%),平均年龄65.7岁,使用标准无动力机械系统进行了永久起搏器/植入式心律转复除颤器(PM/ICD)导线拔除。
手术成功率96.1%,临床成功率97.8%,手术相关死亡率0.18%,主要并发症1.9%(心包填塞1.2%,血胸0.2%,三尖瓣损伤0.3%,中风和肺栓塞<1%)。心脏手术在TLE中的作用可分为五个方面:1. 急诊心脏手术(占所有患者的1.18%),2. 晚期手术干预(TLE相关三尖瓣功能障碍)(0.44%),3. 补充部分成功TLE的心脏手术(0.68%:去除导线碎片),4. 因上述原因通过胸骨切开术植入心外膜起搏器(0.65%),5. TLE后延迟手术干预以放置心外膜左心室导线(0.53%)。此外,手术经验有助于预防和治疗TLE后的伤口感染。
急诊心脏手术(主要因严重出血)仍是最常见的干预原因(占所有手术的33.63%(38/113))。导线管理中手术干预的其他方面包括:补充部分成功TLE的心脏手术、修复或置换因导线拔除导致功能障碍的三尖瓣以及胸骨切开术后植入永久性心外膜起搏导线或心外膜左心室导线以优化心脏再同步化。单一高容量导线拔除中心的经验证实了心脏病专家和心脏外科医生密切合作的必要性,心脏外科医生的作用远不止单纯的手术待命。